Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07507422 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

Study acronym: PERSIST
StatusRecruiting
PhaseNot specified
SponsorMedtronic
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 3 → 6 locationsv3
  2. Recruitment opened
    • Trial sites expanded: 0 → 3 locations
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Medtronic
16 trials monitored
See all monitored trials
The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
Trial Details
NCT Number NCT07507422
Lead Sponsor Medtronic
Conditions
(from sponsor)		 Chronic Pain, Intractable Pain
Related terms Chronic Pain, Intractable Pain
Enrollment 970 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov